France Diabetes Market Report: 2016-2020



IMARC’s new report “France Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the France diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in France. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the France diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the France diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the France diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in France
  • Historical, current and future prevalence of type-1 and type-2 diabetes in France
  • Historical, current and future prevalence of diabetes in the urban and rural regions in France
  • Historical, current and future prevalence of diabetes among males and females in France
  • Historical, current and future prevalence of diabetes among various age groups in France
  • Historical, current and future diagnosis rates for diabetes in France
  • Historical, current and future drug treatment rates for diabetes in France

Comprehensive situation analysis of the France Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in France
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the France Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in France
  • Performance of key classes
  • Performance of key players
  • Market outlook

1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
    3.1 What is Diabetes?
    3.2 Diabetes Diagnosis and Treatment
        3.2.1 Diagnosis
        3.2.2 Treatment
    3.3 Diabetes Complications
4 Key Factors Driving the Diabetes Market in France
5 France Diabetes Epidemiology
    5.1 Diabetes Population and Prevalence Rates
    5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    5.3 Population and Prevalence Rates by Region
    5.4 Population and Prevalence Rates by Gender
    5.5 Population and Prevalence Rates by Age Group
6 France Diabetes Market
    6.1 Historical Market Trends
    6.2 Market Outlook
    6.3 Market Breakup by Segment
    6.4 France Oral Antidiabetics Market
        6.4.1 Historical Market Trends
        6.4.2 Market Breakup by Class
        6.4.3 Market Shares of Key Players
        6.4.4 Market Outlook
    6.5 France Insulin Market
        6.5.1 Historical Market Trends
        6.5.2 Market Breakup by Class
        6.5.3 Market Shares of Key Players
        6.5.4 Market Outlook

 

List of Figures

Figure 3 1: The impact of Diabetes in the Human Body
Figure 3 2: Diabetes Complications
Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035
Figure 4 2: France: Overweight & Obese Population* (in Million), 2010, 2015 & 2020
Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 4 4: France: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %)
Figure 4 5: France: Diabetes Prevalence By Age Groups, (in %)
Figure 5 1: France: Total Number of Diabetes Patients* (in 000), 2008-2015
Figure 5 2: France: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
Figure 5 3: France (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
Figure 5 4: France (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020
Figure 5 5: France (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015
Figure 5 6: France (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 7: France (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
Figure 5 8: France (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Figure 5 9: France: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015
Figure 5 10: France: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020
Figure 6 1: France: Diabetes Drugs Market (in Million US$), 2008 - 2015
Figure 6 2: France: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020
Figure 6 3: France: Diabetes Drugs Market : Breakup of Insulin and Oral Antidiabetics (in %), 2008 – 2015

Figure 6 4: France: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020
Figure 6 5: France: Oral Antidiabetics Market: (in Million US$), 2008 - 2015
Figure 6 6: France: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015
Figure 6 7: France: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 6 8: France: Oral Antidiabetics Market: (in Million US$), 2016 - 2020
Figure 6 9: France: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020
Figure 6 10: France: Insulin Market, (in Million US$), 2008 - 2015
Figure 6 11: France: Breakup of Insulin Market by Class (in %)
Figure 6 12: France: Insulin Market: Sales Share of Key Players (in %)
Figure 6 13: France: Insulin Market Forecast (in Million US$), 2016 - 2020

 

List of Tables

Table 3 1: Diagnosis of Diabetes
Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035
Table 4 2: France: Overweight &Obesity Statistics, 2010, 2015 & 2020
Table 4 3: France: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million)
Table 5 1: France: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020
Table 5 2: France (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 3: France (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 4: France (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Global Biopharmaceutical Manufacturing Market Report 2016-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2016-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2016-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2016-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...


Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2016-2021)

The new report from IMARC group entitled ‘Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2008-2021)’ maps out a comprehensive analysis o...


Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand...


Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Japan Generic Drug Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan. This research report serves as an exceptional tool to understand th...